CLINICAL_TRIALS
trial_result
· 2018-01-23
Clinical Trial Update: Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects [Phase 2]
Summary
A Phase 2a study evaluating the combination of RDEA3170 and allopurinol in gout subjects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23